Potten End, England, United Kingdom
A Pharmaceutical Executive with a strong track record in building teams that deliver results. Has built businesses across multiple geographies and portfolios from start-up biotech to big pharma commercialisation. Extensive international experience including General Management, corporate strategy, commercial leadership, market access, supply chain and operations. Passionate about creating a culture that helps people achieve their full potential, leading with purpose, and improving health outcomes. A values-driven, pragmatic business leader who believes in innovative science to find new solutions for people living with the worlds most challenging illnesses.
Defined and directed the "Go to market“ strategy for the Emerging Market Cluster, of 5 regions and 105 countries. Led the CRM transformation for the European J&J Medical organisation. Role included development of business strategy and had responsibility for managing multiple cross functional teams of professionals (NBD, Commercial Excellence, SFE, Professional Education, Business analytics) and including P&L ownership for Mentor Business Unit Member of EMEA Emerging Market Board
Member of the Janssen ANZ Management Board Responsibility for Neuroscience, Oncology, Virology and Hospital Business Units General Management responsiblitly across the BU's including P&L, overall leadership and talent development Ownership of significant budgets Delivery of operational and long range strategic plans Relationship management with external KOLs (clinical to Government), companies and suppliers
Responsibility for General Management of the New Zealand business. Active member of Medicines New Zealand Board, supporting the NZ Pharmaceutical Industry. Market Access, Reimbursement, Sales, Marketing, Finance and Operations responsibility. Held primary responsibility for cross-functional development of operational and strategic plans across the business